The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Standard & Poor’s Ratings Services affirmed Medtronic’s (NYSE:MDT) long-term debt’s “A+” rating yesterday, after the med-tech titan announced another debt offering.
The rating agency said its view of Medtronic’s senior unsecured notes and its stable rating outlook “reflect the company’s ‘strong’ business risk profile and ‘modest’ financial risk profile.”
Group purchasing organization goliath Premier health care alliance inked 6 new supply deals for surgical endoscopy, video and MRI compatible equipment.
Premier signed 3 new agreements for surgical endoscopy and video equipment with Olympus America (TYO:7733), Gyrus ACMI and Kalamazoo, Mich.-based med-tech titan Stryker Corp. (NYSE:SYK) .
Olympus Corp. (TYO:7733) seems to have reversed its position on payments made during a $2.2 billion acquisition deal for Gyrus Group in 2008, now admitting that recently sacked CEO Michael Woodford was right that nearly one-third of the merger price went to financial advisors.
The Food & Drug Administration issued a Class I recall of an ear implant made by Olympus (OTC:OCPNY) subsidiary Gyrus AMCI, after some of the product was shipped without being sterilized.
The recall covers only a single lot (lot no. MH136952) of the Micron Bobbin Vent Tube T, 1.27mm, made Dec. 17, 2009, and shipped Dec. 22 by Southborough, Mass.-based Gyrus.
